iSpecimen Inc. Files S-1/A Amendment
Ticker: ISPC · Form: S-1/A · Filed: 2025-06-27T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, s-1/a, securities-offering
TL;DR
iSpecimen filed an S-1/A amendment on 6/27/25. Looks like they're still trying to raise capital.
AI Summary
iSpecimen Inc. filed an S-1/A amendment on June 27, 2025, for its registration statement. The company, incorporated in Delaware with its principal executive offices at 8 Cabot Road, Suite 1800, Woburn, MA, is seeking to register securities under the Securities Act of 1933. The filing includes information about the company's business, financial condition, and the terms of the securities being offered.
Why It Matters
This filing indicates iSpecimen Inc. is actively pursuing a securities offering, which could impact its capital structure and future operations.
Risk Assessment
Risk Level: medium — S-1/A filings often relate to capital raises, which can be complex and carry inherent risks for investors.
Key Numbers
- 333-286958 — SEC File Number (Identifies the specific registration filing with the SEC.)
- 251086852 — Film Number (Internal SEC processing number for the filing.)
Key Players & Entities
- iSpecimen Inc. (company) — Registrant
- June 27, 2025 (date) — Filing Date
- 333-286958 (registration_number) — SEC File Number
- 8 Cabot Road, Suite 1800 Woburn, MA 01801 (address) — Principal Executive Offices
- Robert Bradley Lim (person) — Agent for Service
- Yuying Liang (person) — Agent for Service
- Lucosky Brookman LLP (company) — Legal Counsel
- Sichenzia Ross Ference Carmel LLP (company) — Legal Counsel
FAQ
What is the purpose of this S-1/A filing?
This is an Amendment No. 3 to a Form S-1, indicating iSpecimen Inc. is updating its registration statement for a securities offering.
When was this amendment filed?
The amendment was filed with the Securities and Exchange Commission on June 27, 2025.
Where are iSpecimen Inc.'s principal executive offices located?
The principal executive offices are located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.
Who are the agents for service listed in the filing?
Robert Bradley Lim and Yuying Liang are listed as agents for service.
What is the company's Standard Industrial Classification code?
The company's SIC code is 8731, which corresponds to SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.
From the Filing
0001213900-25-059036.txt : 20250627 0001213900-25-059036.hdr.sgml : 20250627 20250627163043 ACCESSION NUMBER: 0001213900-25-059036 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20250627 DATE AS OF CHANGE: 20250627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-286958 FILM NUMBER: 251086852 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 S-1/A 1 ea0246827-s1a3_ispecimen.htm AMENDMENT NO. 3 TO FORM S-1 As filed with the Securities and Exchange Commission on June 27, 2025. Registration No. 333-286958 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 iSpecimen Inc. (Exact name of registrant as specified in its charter) Delaware 8731 27-0480143 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 8 Cabot Road, Suite 1800 Woburn, MA 01801 (781) 301-6700 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Robert Bradley Lim Yuying Liang 8 Cabot Road, Suite 1800 Woburn, MA 01801 (781) 301-6700 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Ross D. Carmel, Esq. Joseph M. Lucosky, Esq. Barry P. Biggar, Esq. Steven A. Lipstein, Esq. Benjamin E. Sklar, Esq. Lucosky Brookman LLP Sichenzia Ross Ference Carmel LLP 101 Wood Ave South 1185 Avenue of the Americas Woodbridge, NJ 08830 New York, New York 10036 (732) 395-4400 (212) 930-9700 Approximate date of commencement of proposed sale to public: As soon as practicable after this Registration Statement is declared effective. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting sta